Obstructive Sleep Apnea Raises the Risk of Sudden Cardiac Death
We interview experts Younghoon Kwon, MD, MS, FACC, and Richard J Castriotta, MD, FCCP, FAASM, about the connections between obstructive sleep apnea-sudden cardiac death.
Cardiovascular and Metabolic Disorders
LDL-C and CV Health Dependent on Age and Specified Endpoint
The researchers wanted to determine the value of LDL-C as a risk biomarker for coronary heart disease, atherosclerotic cardiovascular disease, and stroke events and deaths for people stratified by age.
Cycling Linked to Reduced All-Cause, CVD Mortality in Diabetes
For adults with diabetes, cycling is associated with reduced all-cause and cardiovascular disease (CVD) mortality.
Dapagliflozin Reduces Kidney and Cardiovascular Events Among Patients With Chronic Kidney Disease
Investigators report findings from the Dapagliflozin and Prevention of Adverse outcomes in CKD (DAPA-CKD) study.
Hyperuricemia Increases Risks for Cardiovascular, All-Cause Mortality
Each 1 mg/dL rise in uric acid level was significantly associated with a 21% and 10% increased risk for cardiovascular and all-cause mortality, respectively, a study found.
SHPT, Hyperphosphatemia Linked to CV Event Incidence in Chronic Kidney Disease
The primary objective of this study was to assess whether the potential independent effects of secondary hyperparathyroidism on the risk for CKD progression and cardiovascular event incidence in CKD patients act as effect modifiers.
ACE Inhibitors vs ARBs for First-Line Hypertension Treatment
Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines.
Omega-3 Fatty Acids Tied to Better Cardiovascular Outcomes
Omega-3 fatty acids (FAs) are associated with lower cardiovascular mortality and improved cardiovascular outcomes.
Cardiovascular Drugs Do Not Impact COVID-19 Outcomes
Cardiovascular drugs do not affect COVID-19 outcomes.
Apremilast Associated With Weight Loss and Improved Disease Activity in Patients With Psoriatic Disease
Researchers studied the effect of apremilast on body weight and composition, glucose homeostasis, lipid profiles, and vascular function in psoriatic disease.
- Loading...
Loading...
Next post in Cardiovascular and Metabolic Disorders
Loading... 
Loading...